>
Switch to:

Eidos Therapeutics PS Ratio

: 40,736.67 (As of Today)
View and export this data going back to 2018. Start your Free Trial

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Eidos Therapeutics's share price is $122.210000. Eidos Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00. Hence, Eidos Therapeutics's PS Ratio for today is 40,736.67.

NAS:EIDX' s PS Ratio Range Over the Past 10 Years
Min: 51.26   Med: 73.08   Max: 43860
Current: 40736.67

51.26
43860

During the past 4 years, Eidos Therapeutics's highest PS Ratio was 43860.00. The lowest was 51.26. And the median was 73.08.

NAS:EIDX's PS Ratio is ranked lower than
99.99% of the 938 Companies
in the Biotechnology industry.

( Industry Median: 21.45 vs. NAS:EIDX: 40736.67 )

Eidos Therapeutics's Revenue per Sharefor the three months ended in Sep. 2020 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00.

During the past 12 months, the average Revenue per Share Growth Rate of Eidos Therapeutics was -99.60% per year.

Back to Basics: PS Ratio


Eidos Therapeutics PS Ratio Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Eidos Therapeutics Annual Data
Dec16 Dec17 Dec18 Dec19
PS Ratio 0.00 0.00 0.00 81.06

Eidos Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.81 81.06 69.19 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Eidos Therapeutics PS Ratio Distribution

* The bar in red indicates where Eidos Therapeutics's PS Ratio falls into.



Eidos Therapeutics PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Eidos Therapeutics's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=122.210000/0.003
=40,736.67

Eidos Therapeutics's Share Price of today is $122.210000.
Eidos Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0.003 (Sep. 2020 ) = $0.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Eidos Therapeutics  (NAS:EIDX) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Eidos Therapeutics PS Ratio Related Terms


Eidos Therapeutics PS Ratio Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)